Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.67B
Enterprise Value6.49B
P/E Ratio-46.97
PEG Ratio0.02
Price/Sales Ratio2.46
Price/Book Ratio2.25
Enterprise/Revenue2.8
Enterprise/EBITDA28.64

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.05
Operating Margin0.01
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue3.05B
Revenue/Share1.6
Gross Profit1.44B
EBITDA343.33M
Net Income-104.37M
Diluted EPS-0.08

Balance Sheet

Total Cash181.21M
Total Cash/Share0.11
Total Debt1.06B
Total Debt/Equity0.33
Current Ratio0.97
Book Value Per Share2.01

Price History

52-Week Change-25
52-Week High6.43
52-Week Low4.08
Moving Average 50 Days4.57
Moving Average 200 Days4.71

Statistics

Average Volume8.55M
Shares Outstanding1.4B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.44
Last Split Factor3:1
Last Split DateOctober 20, 2015
AD